-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Sy5M5bo1Y7XluYTgvSXbo0+Se//BZnzDfiFveJ44OFwt+u0ICk/ScXgg/9aoDaR7 rQLV9wYxKXbC51X0k9AD4g== 0001181431-05-001910.txt : 20050106 0001181431-05-001910.hdr.sgml : 20050106 20050106190501 ACCESSION NUMBER: 0001181431-05-001910 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041231 FILED AS OF DATE: 20050106 DATE AS OF CHANGE: 20050106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON FRANKLIN P JR CENTRAL INDEX KEY: 0000904017 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 05516770 BUSINESS ADDRESS: STREET 1: 2275 EAST BAYSHORE ROAD STREET 2: SUITE 1250 CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 6504347400 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 5 1 rrd63962.xml FORM 5 X0202 5 2004-12-31 0 0 0 0000318154 AMGEN INC AMGN 0000904017 JOHNSON FRANKLIN P JR ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 0 0 0 Common Stock 2004-12-03 5 G 0 22500 0 D 880222 D Common Stock 2004-12-03 5 G 0 2000 0 D 822888 I By Spouse (FPJ 12.03.04) Does not include (i) 634,400 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner and (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. /s/ Franklin P. Johnson, Jr. 2005-01-05 -----END PRIVACY-ENHANCED MESSAGE-----